A.S.P.E.N. clinical guidelines: Nutrition support of children with human immunodeficiency virus infection

Journal of Parenteral and Enteral Nutrition

Volumn 33, Issue 6, 2009, Pages 588-606

  Sabery, Nasim ^a   Duggan, Christopher ^a  

^a BOSTON CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TOCOPHEROL; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BETA CAROTENE; CALCIUM; FOLIC ACID; IRON; MULTIVITAMIN; NEVIRAPINE; PLACEBO; PROTEINASE INHIBITOR; RETINOL; RETINOL PALMITATE; RNA DIRECTED DNA POLYMERASE INHIBITOR; TRACE ELEMENT; VITAMIN D; ZIDOVUDINE; ZINC;

ANTHROPOMETRY; ARTIFICIAL MILK; BODY COMPOSITION; BODY FAT DISTRIBUTION; BODY WEIGHT; BONE DENSITY; BREAST FEEDING; CHILD GROWTH; ELEMENTAL DIET; ENTERIC FEEDING; FETUS DEATH; FETUS OUTCOME; GROWTH DISORDER; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HIV ASSOCIATED LIPODYSTROPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HYPERCHOLESTEROLEMIA; HYPERTRIGLYCERIDEMIA; INFECTION PREVENTION; INSULIN RESISTANCE; LACTATION; MACRONUTRIENT; MALNUTRITION; MORTALITY; NUTRITIONAL ASSESSMENT; NUTRITIONAL DEFICIENCY; NUTRITIONAL SUPPORT; PARENTERAL NUTRITION; PRACTICE GUIDELINE; PREGNANCY; PRIORITY JOURNAL; PROTEINASE INHIBITION; REVIEW; SINGLE DRUG DOSE; TUBE FEEDING; VERTICAL TRANSMISSION; VITAMIN SUPPLEMENTATION; WASTING SYNDROME;

ANTI-RETROVIRAL AGENTS; CHILD; CHILD, PRESCHOOL; DIETARY SUPPLEMENTS; FEMALE; HIV INFECTIONS; HIV-1; HUMANS; INFANT; LIPODYSTROPHY; MICRONUTRIENTS; NUTRITION ASSESSMENT; NUTRITION THERAPY; NUTRITIONAL SUPPORT; PREGNANCY;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 70449512098     PISSN: 01486071     EISSN: None     Source Type: Journal    
DOI: 10.1177/0148607109346276     Document Type: Review

References (74)

1. A.S.P.E.N. Board of Directors. Guidelines for use of total parenteral nutrition in the hospitalized adult patient. JPEN J Parenter Enteral Nutr. 1986 ; 10 (5). 441-445.
2. A.S.P.E.N. Board of Directors. Guidelines for the use of parenteral and enteral nutrition in adult and pediatric patients. JPEN J Parenter Enteral Nutr. 2002 ; 26 (1 suppl). 1SA - 138SA.
3. A.S.P.E.N. Board of Directors. Guidelines for the Use of Parenteral and Enteral Nutrition in Adult and Pediatric Patients. JPEN J Parenter Enteral Nutr. 1993 ; 17 (suppl 4). 1SA - 52SA.
4. Committee to Advise Public Health Service on Clinical Practice Guidelines (Institute of Medicine). Clinical Practice Guidelines: Directions for a New Program. Washington, DC: National Academy Press ; 1990: 58.
5. Seres D., Compher C., Seidner D., Byham-Gray L., Gervasio J., McClave S. 2005 American Society for Parenteral and Enteral Nutrition (A.S.P.E.N.) Standards and Guidelines survey Nutr Clin Pract. 2006 ; 21 (5). 529-532.
6. Dellinger RP, Carlet JM, Masur H., et al. Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med. 2004 ; 32 (3). 858-873.
7. Guyatt GH, Haynes RB, Jaeschke RZ, et al. Users' Guides to the Medical Literature, XXV: evidence-based medicine: principles for applying the Users' Guides to patient care. Evidence-Based Medicine Working Group. JAMA. 2000 ; 284 (10). 1290-1296.
8. Bailey RC, Kamenga MC, Nsuami MJ, Nieburg P., St Louis ME. Growth of children according to maternal and child HIV, immunological and disease characteristics: a prospective cohort study in Kinshasa, Democratic Republic of Congo. Int J Epidemiol. 1999 ; 28 (3). 532-540.
9. McKinney RE Jr, Robertson JW Effect of human immunodeficiency virus infection on the growth of young children. Duke Pediatric AIDS Clinical Trials Unit. J Pediatr. 1993 ; 123 (4). 579-582. (Pubitemid 23287529)
10. Miller TL, Easley KA, Zhang W., et al. Maternal and infant factors associated with failure to thrive in children with vertically transmitted human immunodeficiency virus-1 infection: the prospective, P2C2 human immunodeficiency virus multicenter study. Pediatrics. 2001 ; 108 (6). 1287-1296.
11. CDC 1994 Revised classification system for human immunodeficiency infection in children less than 13 years of age. In: Mmwr, ed. Vol. 43: Centers for Disease Control Surveillance Summary ; 1994: 1-9.
12. Berhane R., Bagenda D., Marum L., et al. Growth failure as a prognostic indicator of mortality in pediatric HIV infection. Pediatrics. 1997 ; 100 (1). E7.
13. Lepage P., Msellati P., Hitimana DG, et al. Growth of human immunodeficiency type 1-infected and uninfected children: a prospective cohort study in Kigali, Rwanda, 1988 to 1993. Pediatr Infect Dis J. 1996 ; 15 (6). 479-485.
14. Villamor E., Misegades L., Fataki MR, Mbise RL, Fawzi WW Child mortality in relation to HIV infection, nutritional status, and socio-economic background. Int J Epidemiol. 2005 ; 34 (1). 61-68.
15. Newell ML, Borja MC, Peckham C. Height, weight, and growth in children born to mothers with HIV-1 infection in Europe. Pediatrics. 2003 ; 111 (1). e52 - e60.
16. Verweel G., van Rossum AM, Hartwig NG, Wolfs TF, Scherpbier HJ, de Groot R. Treatment with highly active antiretroviral therapy in human immunodeficiency virus type 1-infected children is associated with a sustained effect on growth. Pediatrics. 2002 ; 109 (2). E25.
17. Miller TL, Mawn BE, Orav EJ, et al. The effect of protease inhibitor therapy on growth and body composition in human immunodeficiency virus type 1-infected children. Pediatrics. 2001 ; 107 (5). E77.
18. Miller TL, Evans SJ, Orav EJ, Morris V., McIntosh K., Winter HS Growth and body composition in children infected with the human immunodeficiency virus-1. Am J Clin Nutr. 1993 ; 57 (4). 588-592.
19. Taylor P., Worrell C., Steinberg SM, et al. Natural history of lipid abnormalities and fat redistribution among human immunodeficiency virus-infected children receiving long-term, protease inhibitor-containing, highly active antiretroviral therapy regimens. Pediatrics. 2004 ; 114 (2). e235 - e242.
20. Jaquet D., Levine M., Ortega-Rodriguez E., et al. Clinical and metabolic presentation of the lipodystrophic syndrome in HIV-infected children. AIDS. 2000 ; 14 (14). 2123-2128.
21. Arpadi SM, Horlick MN, Wang J., Cuff P., Bamji M., Kotler DP Body composition in prepubertal children with human immunodeficiency virus type 1 infection. Arch Pediatr Adolesc Med. 1998 ; 152 (7). 688-693.
22. Rollins NC, van den Broeck J., Kindra G., Pent M., Kasambira T., Bennish ML The effect of nutritional support on weight gain of HIV-infected children with prolonged diarrhoea. Acta Paediatr. 2007 ; 96 (1). 62-68.
23. Miller TL, Awnetwant EL, Evans S., Morris VM, Vazquez IM, McIntosh K. Gastrostomy tube supplementation for HIV infected children. Pediatrics. 1995 ; 96 (4 Pt 1). 696-702.
24. Henderson RA, Saavedra JM, Perman JA, Hutton N., Livingston RA, Yolken RH Effect of enteral tube feeding on growth of children with symptomatic human immunodeficiency virus infection. J Pediatr Gastroenterol Nutr. 1994 ; 18 (4). 429-434.
25. Amadi B., Mwiya M., Chomba E., et al. Improved nutritional recovery on an elemental diet in Zambian children with persistent diarrhoea and malnutrition. J Trop Pediatr. 2005 ; 51 (1). 5-10.
26. Guillen S., Ramos JT, Resino R., Bellon JM, Munoz MA Impact on weight and height with the use of HAART in HIV+ children. Pediatr Infect Dis J. 2007 ; 26 (4). 334-338.
27. Scherpbier HJ, Bekker V., van Leth F., Jurriaans S., Lange JM, Kuijpers TW Long-term experience with combination antiretroviral therapy that contains nelfinavir for up to 7 years in a pediatric cohort. Pediatrics. 2006 ; 117 (3). e528 - e536.
28. Nachman SA, Lindsey JC, Moye J., et al. Growth of human immunodeficiency virus-infected children receiving highly active antiretroviral therapy. Pediatr Infect Dis J. 2005 ; 24 (4). 352-357.
29. Arpadi SM Growth failure in children with HIV infection. J Acquir Immune Defic Syndr. 2000 ; 25 (suppl 1). S37 - S42.
30. Ene L., Goetghebuer T., Hainaut M., Peltier A., Toppet V., Levy J. Prevalence of lipodystrophy in HIV+ children: a cross-sectional study. Eur J Pediatr. 2007 ; 166 (1). 13-21.
31. Sanchez Torres AM, Munoz Muniz R., Madero R., Borque C., Garcia-Miguel MJ, De Jose Gomez Mi Prevalence of fat redistribution and metabolic disorders in human immunodeficiency virus-infected children. Eur J Pediatr. 2005 ; 164 (5). 271-276.
32. Carter RJ, Wiener J., Abrams EJ, et al. Dyslipidemia among perinatally HIV+ children enrolled in the PACTS-HOPE cohort, 1999-2004: a longitudinal analysis. J Acquir Immune Defic Syndr. 2006 ; 41 (4). 453-460.
33. Beregszaszi M., Dollfus C., Levine M., et al. Longitudinal evaluation and risk factors of lipodystrophy and associated metabolic changes in HIV+ children. J Acquir Immune Defic Syndr. 2005 ; 40 (2). 161-168.
34. Farley J., Gona P., Crain M., et al. Prevalence of elevated cholesterol and associated risk factors among perinatally HIV+ children (4-19 years old) in Pediatric AIDS Clinical Trials Group 219C. J Acquir Immune Defic Syndr. 2005 ; 38 (4). 480-487.
35. Arpadi SM, Cuff PA, Kotler DP, et al. Growth velocity, fat-free mass and energy intake are inversely related to viral load in HIV+ children. J Nutr. 2000 ; 130 (10). 2498-2502.
36. Amaya RA, Kozinetz CA, McMeans A., Schwarzwald H., Kline MW Lipodystrophy syndrome in human immunodeficiency virus-infected children. Pediatr Infect Dis J. 2002 ; 21 (5). 405-410.
37. Hartman K., Verweel G., de Groot R., Hartwig NG Detection of lipoatrophy in human immunodeficiency virus-1-infected children treated with highly active antiretroviral therapy. Pediatr Infect Dis J. 2006 ; 25 (5). 427-431.
38. Antiretroviral therapy, fat redistribution and hyperlipidaemia in HIV+ children in Europe. Aids. 2004 ; 18 (10). 1443-1451.
39. Fawzi WW, Hunter DJ Vitamins in HIV disease progression and vertical transmission. Epidemiology. 1998 ; 9 (4). 457-466.
40. Fawzi WW, Msamanga GI, Spiegelman D., et al. Randomised trial of effects of vitamin supplements on pregnancy outcomes and T cell counts in HIV-1-infected women in Tanzania. Lancet. 1998 ; 351 (9114). 1477-1482.
41. McGrath N., Bellinger D., Robins J., Msamanga GI, Tronick E., Fawzi WW Effect of maternal multivitamin supplementation on the mental and psychomotor development of children who are born to HIV-1-infected mothers in Tanzania. Pediatrics. 2006 ; 117 (2). e216 - e225.
42. Villamor E., Saathoff E., Bosch RJ, et al. Vitamin supplementation of HIV+ women improves postnatal child growth. Am J Clin Nutr. 2005 ; 81 (4). 880-888.
43. Fawzi WW, Villamor E., Msamanga GI, et al. Trial of zinc supplements in relation to pregnancy outcomes, hematologic indicators, and T cell counts among HIV-1-infected women in Tanzania. Am J Clin Nutr. 2005 ; 81 (1). 161-167.
44. Humphrey JH, Iliff PJ, Marinda ET, et al. Effects of a single large dose of vitamin A, given during the postpartum period to HIV-positive women and their infants, on child HIV infection, HIV-free survival, and mortality. J Infect Dis. 2006 ; 193 (6). 860-871.
45. Humphrey JH, Hargrove JW, Malaba LC, et al. HIV incidence among post-partum women in Zimbabwe: risk factors and the effect of vitamin A supplementation. AIDS. 2006 ; 20 (10). 1437-1446.
46. Kumwenda N., Miotti PG, Taha TE, et al. Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi. Clin Infect Dis. 2002 ; 35 (5). 618-624.
47. Coutsoudis A., Pillay K., Spooner E., Kuhn L., Coovadia HM Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child HIV-1 transmission in Durban, South Africa. South African Vitamin A Study Group. AIDS. 1999 ; 13 (12). 1517-1524.
48. Fawzi WW, Msamanga GI, Hunter D., et al. Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS. 2002 ; 16 (14). 1935-1944.
49. Wiysonge CS, Shey MS, Sterne JA, Brocklehurst P. Vitamin A supplementation for reducing the risk of mother-to-child transmission of HIV infection. Cochrane Database Syst Rev. 2005 ;(4). CD003648.
50. Fawzi WW, Msamanga GI, Wei R., et al. Effect of providing vitamin supplements to human immunodeficiency virus-infected, lactating mothers on the child's morbidity and CD4+ cell counts. Clin Infect Dis. 2003 ; 36 (8). 1053-1062.
51. Kruzich LA, Marquis GS, Carriquiry AL, Wilson CM, Stephensen CB US youths in the early stages of HIV disease have low intakes of some micronutrients important for optimal immune function. J Am Diet Assoc. 2004 ; 104 (7). 1095-1101.
52. Jacobson DL, Spiegelman D., Duggan C., et al. Predictors of bone mineral density in human immunodeficiency virus-1 infected children. J Pediatr Gastroenterol Nutr. 2005 ; 41 (3). 339-346.
53. Campa A., Shor-Posner G., Indacochea F., et al. Mortality risk in selenium-deficient HIV-positive children. J Acquir Immune Defic Syndr Hum Retrovirol. 1999 ; 20 (5). 508-513.
54. Fawzi WW, Mbise RL, Hertzmark E., et al. A randomized trial of vitamin A supplements in relation to mortality among human immunodeficiency virus-infected and uninfected children in Tanzania. Pediatr Infect Dis J. 1999 ; 18 (2). 127-133.
55. Coutsoudis A., Bobat RA, Coovadia HM, Kuhn L., Tsai WY, Stein ZA The effects of vitamin A supplementation on the morbidity of children born to HIV+ women. Am J Public Health. 1995 ; 85 (8 pt 1). 1076-1081.
56. Bobat R., Coovadia H., Stephen C., et al. Safety and efficacy of zinc supplementation for children with HIV-1 infection in South Africa: a randomised double-blind placebo-controlled trial. Lancet. 2005 ; 366 (9500). 1862-1867.
57. Tremeschin MH, Cervi MC, Camelo Júnior JS, et al. Niacin nutritional status in HIV type 1-positive children: preliminary data.acute J Pediatr Gastroenterol Nutr. 2007 ; 44 (5). 629-633.
58. Semba RD, Ndugwa C., Perry RT, et al. Effect of periodic vitamin A supplementation on mortality and morbidity of human immunodeficiency virus-infected children in Uganda: a controlled clinical trial. Nutrition. 2005 ; 21 (1). 25-31.
59. Nduati R., John G., Mbori-Ngacha D., et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA. 2000 ; 283 (9). 1167-1174.
60. Iliff PJ, Piwoz EG, Tavengwa NV, et al. Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-free survival. AIDS. 2005 ; 19 (7). 699-708.
61. Dunn DT, Newell ML, Ades AE, Peckham CS Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet. 1992 ; 340 (8819). 585-588.
62. Kourtis AP, Jamieson DJ, de Vincenzi I., et al. Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol. 2007 ; 197 (3 suppl). S113 - S122.
63. Who UUU. Report of a technical consultation held on behalf of the Inter-agency Task Team (IATT) on Prevention of HIV infections in pregnant women, mother and their infants. Paper presented at: HIV and infant feeding: new evidence and programmatic experience ; October 2006 ; Geneva, Switzerland.
64. Bulteel N., Henderson P. Evidence behind the WHO guidelines: hospital care for children: what are the risks of formula feeding in children of HIV+ mothers J Trop Pediatr. 2007 ; 53 (6). 370-373.
65. Bulteel N., Henderson P. Evidence behind the WHO guidelines: hospital care for children: what are the risks of HIV transmission through breastfeeding J Trop Pediatr. 2007 ; 53 (5). 298-302.
66. Newell ML, Coovadia H., Cortina-Borja M., Rollins N., Gaillard P., Dabis F. Mortality of infected and uninfected infants born to HIV+ mothers in Africa: a pooled analysis. Lancet. 2004 ; 364 (9441). 1236-1243.
67. Coovadia HM, Rollins NC, Bland RM, et al. Mother-to-child transmission of HIV-1 infection during exclusive breastfeeding in the first 6 months of life: an intervention cohort study. Lancet. 2007 ; 369 (9567). 1107-1116.
68. Becquet R., Ekouevi DK, Menan H., et al. Early mixed feeding and breastfeeding beyond 6 months increase the risk of postnatal HIV transmission: ANRS 1201/1202 Ditrame Plus, Abidjan, Cote d'Ivoire. Prev Med. 2008 ; 47 (1). 27-33.
69. Rollins NC, Becquet R., Bland RM, Coutsoudis A., Coovadia HM, Newell ML Infant feeding, HIV transmission and mortality at 18 months: the need for appropriate choices by mothers and prioritization within programmes. AIDS. 2008 ; 22 (17). 2349-2357.
70. Kuhn L., Aldrovandi GM, Sinkala M., et al. Effects of early, abrupt weaning on HIV-free survival of children in Zambia. N Engl J Med. 2008 ; 359 (2). 130-141.
71. Palombi L., Marazzi MC, Voetberg A., Magid NA Treatment acceleration program and the experience of the DREAM program in prevention of mother-to-child transmission of HIV. AIDS. 2007 ; 21 (suppl 4). S65 - S71.
72. Taha TE, Hoover DR, Kumwenda NI, et al. Late postnatal transmission of HIV-1 and associated factors. J Infect Dis. 2007 ; 196 (1). 10-14.
73. Thior I., Lockman S., Smeaton LM, et al. Breastfeeding plus infant zidovudine prophylaxis for 6 months vs formula feeding plus infant zidovudine for 1 month to reduce mother-to-child HIV transmission in Botswana: a randomized trial: the Mashi Study. JAMA. 2006 ; 296 (7). 794-805.
74. Coutsoudis A., Pillay K., Spooner E., Coovadia HM, Pembrey L., Newell ML Morbidity in children born to women infected with human immunodeficiency virus in South Africa: does mode of feeding matter Acta Paediatr. 2003 ; 92 (8). 890-895.